| Bridgette Whitten, | |
|
6802 Mcclean Blvd, Parkville, MD 21234-7200 | |
| (410) 444-3800 | |
| Not Available |
| Full Name | Bridgette Whitten |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 6802 Mcclean Blvd, Parkville, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184395295 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 27759 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bridgette Whitten, 6802 Mcclean Blvd, Parkville, MD 21234-7260 Ph: (410) 444-3800 | Bridgette Whitten, 6802 Mcclean Blvd, Parkville, MD 21234-7200 Ph: (410) 444-3800 |
News Archive
St. Jude Medical, Inc. today announced it has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in the IRASE AF (IRrigated Ablation System Evaluation for AF) trial, a multicenter, randomized, single-blind study evaluating the safety and efficacy of the company's Duo 12 port open irrigated catheter ablation system for treatment of Atrial Fibrillation (AF). AF is the most common cardiac arrhythmia (abnormal heartbeat), affecting an estimated 3.3 million Americans and millions more worldwide.
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.
Pakistan's Foreign Minister Shah Mehmood Qureshi said Tuesday the country plans to sell farmland to foreign investors despite warnings by the U.N. that doing so could compromise farmers' rights, Reuters reports.
Oxygen Biotherapeutics, Inc. has announced that the company has developed a gel-like form of Oxycyte that it intends to investigate as a topical application for open wounds, abrasions and burns. Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.
Since 2003, breast augmentation utilizing stem cells from autologous fat has been developed enabling silicon-free breast reconstruction following cancer surgery. Till now though, it was unclear whether this might reactivate the cancer again. However, University of Pittsburgh researchers led by Prof. Albert Donnenberg have now demonstrated that stem cell-enriched autologous fat is safe even in the presence of inactive tumor cells.
› Verified 2 days ago
Mrs. Danni Kay Davis, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2914 E Joppa Rd Ste 100, Parkville, MD 21234 Phone: 410-905-4113 Fax: 410-905-4113 | |
Mr. Andrew Musa Forday-watson, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1451 Dartmouth Ave, Parkville, MD 21234 Phone: 443-977-3048 | |
Ms. Mirose Pierville, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8203 Harford Rd, Parkville, MD 21234 Phone: 410-330-9020 | |
Mrs. Krista A Trahan, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2914 E Joppa Rd, Parkville, MD 21234 Phone: 443-461-5320 | |
Jessica Kell, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8415 Nunley Dr Apt B, Parkville, MD 21234 Phone: 410-610-5440 | |
Stevann Waithe, LGSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3126 East Ave, Parkville, MD 21234 Phone: 443-825-8931 | |
Mrs. Jessica Leigh Jones, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 27 Bernadotte Ct, Parkville, MD 21234 Phone: 410-925-1383 |